The latter study also demonstrated that TIGIT expression on CD8+ T cells is not only elevated in acute myeloid leukemia (AML) patients, but that high TIGIT levels also correlate with primary refractory disease, as well as leukemia relapse following allogenic stem cell transplantation. The gene discussed is CD8A; the disease is leukemia.